Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.

PLoS One · 2012 · PMC3328442 · PMID 22530013

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Three of the four doses of mAb 3C5 provided highly significant protection with the 125 μg dose providing optimal protection (88% survival).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.